Concepedia

Successful Treatment With Dabrafenib (GSK2118436) in a Patient With Ganglioglioma

Kent C. Shih, Mythili Shastry, Jeffrey T. Williams, Peter F. Jelsma, Steven R. Abram, Kanyalakshmi Ayyanar, Howard A. Burris, Jeffrey R. Infante

Journal of Clinical Oncology · 2014 · 30 citations · 11 references

DOIFull text

Open access

Concepts

References

11

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Lev Demidov et al. · The Lancet · 2012 · 3K citations

, , +11

Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial

Gerald S. Falchook, Georgina V. Long, Razelle Kurzrock et al. · The Lancet · 2012 · 933 citations · Full text

, , +12

Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial

Georgina V. Long, Uwe Trefzer, Michael A. Davies et al. · The Lancet Oncology · 2012 · 908 citations

, , +12

Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow‐up of 8 years

Cordelia Luyken, Ingmar Blümcke, Rolf Fimmers et al. · Cancer · 2004 · 346 citations

, , +13

Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas

Margaret Dougherty, Mariarita Santi, Marcia S. Brose et al. · Neuro-Oncology · 2010 · 323 citations · Full text

, , +17